“…During the past decades, many vaccine candidates against Trichinellosis have been investigated and reported, including those based on crude larval extracts ( Deville et al, 2005 ), excretory-secretory (ES) products ( Dea-Ayuela et al, 2006 ), DNA ( Wang et al, 2016 ), recombinant proteins ( Bi et al, 2015 ), peptides ( Castillo et al, 2013 ) or combined DNA with protein ( Gu et al, 2014 ), all of them induced different extents of partial protective immunity in animal models. However, due to the complexity of the life cycle, diversity of stage-specific antigens and immune-evasion strategies of T. spiralis ( Zhang et al, 2011 ; Sun et al, 2015 ), researchers face the challenges in developing effective vaccines against Trichinellosis.…”